Intravital Microscopy of Monocyte Homing and Tumor-Related Angiogenesis in a Murine Model of Peripheral Arterial Disease

Summary

Monocytes are important mediators of arteriogenesis in the context of peripheral arterial disease. Using a basement membrane-like matrix and intravital microscopy, this protocol investigates monocyte homing and tumor-related angiogenesis after monocyte injection in the femoral artery ligation murine model.

Abstract

The therapeutic goal for peripheral arterial disease and ischemic heart disease is to increase blood flow to ischemic areas caused by hemodynamic stenosis. Vascular surgery is a viable option in selected cases, but for patients without indications for surgery such as progression to rest pain, critical limb ischemia, or major disruptions to life or work, there are few possibilities for mitigating their disease. Cell therapy via monocyte-enhanced perfusion through the stimulation of collateral formation is one of a few non-invasive options.

Our group examines arteriogenesis after monocyte transplantation into mice using the hindlimb ischemia model. Previously, we have demonstrated improvement in hindlimb perfusion using tetanus-stimulated syngeneic monocyte transplantation. In addition to the effects on the collateral formation, tumor growth could be affected by this therapy as well. To investigate these effects, we use a basement membrane-like matrix mouse model by injecting the extracellular matrix of the Engelbreth-Holm-Swarm sarcoma into the flank of the mouse, after occlusion of the femoral artery.

After the artificial tumor studies, we use intravital microscopy to study in vivo tumor-angiogenesis and monocyte homing within collateral arteries. Previous studies have described the histological examination of animal models, which presupposes subsequent analysis to post-mortem artifacts. Our approach visualizes monocyte homing to areas of collateralization in real time sequences, is easy to perform, and investigates the process of arteriogenesis and tumor angiogenesis in vivo.

Introduction

Cardiovascular diseases, including coronary heart disease or peripheral arterial disease, are the most common causes of death globally¹. Cell therapy is a promising approach to treat cardiovascular disease, particularly for people who are not able to undergo surgical interventions. There are several approaches to use cells or their secreted substances as a therapeutic tool^2,3, with the overall goal to improve the perfusion and maintain function of ischemic and underperfused tissue. One attempt to achieve this goal is to improve arteriogenesis, which enhances the development of collateral arteries. Monocytes are an important cell type associated with collateralization. Our group has focused on researching the effects of monocytes in areas of inflammation^4,5, in particular using the hindlimb ischemia model to induce ischemia and subsequent inflammation⁶. Monocytes home to areas of inflammation and cause complex systemic responses that lead to the development of collateralization⁷.

With the use of intravital microscopy, we can study the behavior of these cells in vivo and observe the homing of injected monocytes to areas of inflammation. Most former studies only describe post mortem analyses, which hold disadvantages including an introduction of histological artifacts and large numbers of animal required for preparations. With our approach, we can investigate immunological processes and collateral formation via live imaging at multiple time points.

In addition to the development of collateral arteries in ischemic areas, monocytes also influence tumor growth. To investigate these processes, we inject a basement membrane-like matrix extracted from the Engelbreth-Holm-Swarm mouse sarcoma, a tumor rich in extracellular matrix proteins⁸, and analyze using intravital microscopy. This matrix is used to screen test molecules for either endothelial cell network formation or anti-cancer therapies through angiogenic inhibition; in this case, we will assess the tumor angiogenic potential of monocytes for cell therapy^9,10,11.

The aim of this protocol is to demonstrate an easy and efficient way to study immunological processes caused by ischemia in an in vivo model. We can generate a more realistic test environment compared to histological workup of post mortem muscle tissue.

Protocol

Our study was performed with permission of the state of Saxony-Anhalt, Landesverwaltungsamt Halle, according to section 8 of the German law for animal protection. (§ 8, paragraph 1 of the German law for animal protection from 18.05.2016 - BGBI. I S. 1206, 1313, § 31 TierSchVersV from 13.08.2013).

NOTE: For the experiments here, 8 to 12 week old male BALB/c mice were used, and human monocytes from blood donors were used for the visualization of monocytes via intravital microscopy.

1. Cell Preparation

NOTE: For the isolation of monocytes, please see our previous published video on JoVE for instructions: "Isolation and Intravenous Injection of Murine Bone Marrow Derived Monocytes" by Wagner et al.⁴

NOTE: When working with the cells all steps must be sterile to avoid contamination.

1. Cell Staining with 3,3'-Dioctadecyloxacarbocyanine Perchlorate
   1. Resuspend the cells in serum free culture medium with a density of 1 x 10⁶ cells/mL.
      NOTE: Only serum free medium enables an efficient staining, since the lipophilic dye would otherwise already be captured by lipophilic components of the serum.
   2. Add 5 µL of 1 mM 3,3'-Dioctadecyloxacarbocyanine perchlorate in dimethylformamide to 1 mL of the cell suspension and resuspend carefully.
   3. Incubate the cell solution at 37 °C for 20 min.
   4. Centrifuge the cells at 37 °C and 500 x g for 5 min.
   5. Dislodge the supernatant and resuspend the cells with 37 °C warm fetal calf serum supplemented medium.
   6. Repeat the steps 1.1.4 and 1.1.5 twice.
   7. Count the cells with the formula:
      
   8. Resuspend the cells with 150 µL sterile 0.9% NaCl solution.
   9. Inject the cells into the tail vein.

2. Anesthesia

1. Inhalation Anesthesia
   1. Vaporize isoflurane with the help of a vaporizer using a concentration of 5% in a closed bin under a chemical safety hood.
   2. Handle the mouse carefully and put it into the bin.
   3. Handle the animal by the skin of the posterior neck after it has stopped moving.
2. Intraperitoneal Anesthesia
   NOTE: Use isoflurane anesthesia, described under step 2.1, to perform an intraperitoneal injection. With the fast recovery and short-acting narcotic effect of the isoflurane anesthesia, it is easier to handle the mouse and inject intraperitoneal anesthesia.
   1. Use a solution of 2.4 mL Ketamine (10%), 0.8 mL Xylazine (2%), and 6.8 mL NaCl (0.9%) for the intraperitoneal injection.
   2. Weigh the animal before applying anesthetic.
      NOTE: The formula for the anesthetic is:
      
   3. Use a 1 mL insulin syringe with a 30 G needle to inject the solution into the left underbelly.
   4. Place the mouse in its cage and wait for narcotic effect.
      NOTE: The narcotic effect normally appears within 5 min if the injection was successful. The correct depth of the anesthesia can be determined by the absence of either the lid reflex or reaction to toe pinch, as well as a regular, controlled rate of breathing.

3. Implantation of Basement Membrane-like Matrix

NOTE: This method is used by our group to study tumor angiogenesis after monocyte injection. Depending on the experiments, growth factors can be added to the basement membrane-like matrix. We performed femoral artery ligation before injecting the tumor in the flank of the mouse. The matrix must have a temperature of 4 °C for the injection. At this temperature, the matrix is fluid; the gel hardens to a solid at body temperature (37 °C). For better visibility of the subcutaneous matrix plug, shave the skin of the mouse at the injection site.

Note:Optional: Add 100 ng basic fibroblast growth factor, 300 ng vascular endothelial growth factor, and 26 I.U. heparin under sterile conditions to the basement membrane-like matrix.

1. Load 1 mL of matrix into a 30 G insulin syringe and store on ice until use.
2. Lay the animal on the table and hold the skin of the mouse next to the injection site on the flank.
3. Inject 500 µL of the basement membrane-like matrix subcutaneously.
   NOTE: For practical reasons, it is necessary to inject the basement membrane-like matrix compactly at one location to avoid subcutaneous dispersion. It will be easier to dislodge the artificial tumor from the tissue after sacrificing the mouse at the end of the experiment.

4. Tail Vein Injection

NOTE: Practice the tail vein injection with NaCl solution on test animals before experimentation. If the monocytes cannot be adequately injected in the tail vein, there will be no systemic effect on the collateralization. In this protocol, we injected 2.5 million monocytes. Try to inject no more than 5 µL/g of bodyweight.

1. Use the monocyte solution prepared under step 1.1.8 containing 2.5 million monocytes.
2. Use a 30 G needle and a 1 mL insulin syringe for the injection.
3. Carefully handle the mouse, restrain the animal in the restrainer, and make sure the mouse is not harmed and has adequate space for breathing.
4. Put the restrainer on the heating pad so that the tail can contact the plate.
5. Identify the tail veins, which are located on the lateral side of the tail.
6. Turn the tail 90 °, so the tail vein appears on the upper side of the tail.
7. Disinfect the injection side before injecting the monocytes.
8. Try to inject the monocyte solution in a flat angle with the bevel of the needle facing up.
   NOTE: Stop the injection if a blister appears, as this is a sign of a failed injection. Attempt the procedure again more proximally.
9. Stop bleeding at the injection site by applying gentle pressure on the tail for about 60s.
10. Observe the animal for 30 min to monitor for systemic side effects and place the mouse in its cage after the animal has fully recovered.

5. Intravital Microscopy

1. Preparation
   1. Place the anesthetized mouse on the heating pad (37 °C) to keep a constant temperature and fix the paws in place with adhesive tape.
   2. Disinfect the skin at the site of the leg or flank that is used for microscopy.
   3. Shave the region of interest for better handling and to avoid interference with hair.
   4. Excise the skin with a sterile scalpel and fine forceps in a square area of 0.5 x 0.5 cm.
      NOTE: It is important to keep the region of interest moist; otherwise, the quality of images and tissue will be compromised. NaCl solution can be used to moisten the area.
   5. Place the leg between two adjustable stamps and position a cover glass on top of the stamps.
   6. Ensure the tissue is wet and is in contact with the glass.
   7. Inject 50 µL rhodamine dextran retrobulbar into the venous system for better visibility of the vessels.
   8. Start microscopy and adjust the position of the leg if needed.
2. Intravital microscopy settings
   1. Turn on the microscope, computer, electronic interfaces, and lasers.
   2. Turn on the heating unit of incubation chamber and/or heating stage (plate/pad), and set the temperature to 37 °C.
   3. Start the acquisition software. If the microscope is equipped with a resonant scanner, select this fast scanning mode.
   4. Wait until the temperature reaches a constant level (35 - 37 °C)
      NOTE: A stable temperature is important for: (a) the mouse, which under anesthesia cannot control its body temperature, and (b) avoiding or at least minimizing focal drift. This could take 1 h to several hours, depending on the surrounding conditions (e.g., air conditioning system and the number of heat sources in the room, including people). If immersion objectives are used, the contact zone between the lens and cover glass (or tissue) is a typical source of instability. Heating the lens with an objective heater may help; alternatively, a microscope with an autofocus system is highly recommended.
   5. Select a magnification lens with a high numeral aperture that fulfils the resolution requirements of the experiment (see note at the end of this section).
   6. Optimize the microscope settings with respect to gain, channel settings, scan speed, pixel resolution, depth volume, step size, and averaging before placing the experimental animal on the stage.
   7. Scan bidirectionally to reduce acquisition time.
   8. Place the anesthetized mouse on the prewarmed microscope stage after the microscope has reached stable conditions and the settings have been tested with the help of a dummy.
   9. Bring the region of interest within the basement membrane-like matrix into focus by using bright light illumination and inspect briefly the capillaries by ultraviolet light with adequate filter settings for the applied fluorophores.
   10. Switch to scanning mode; start scanning at low resolution 256 x 256 mode and enhance gain and laser power until a signal is observed on the monitor.
   11. Focus on the structure of interest. Zoom in until all details are visible.
   12. Define "start" and "end" positions in the axial direction.
   13. Stop scanning.
   14. Define stepping size (e.g., 0.5 µm) and number of focal planes (e.g., 10 - 20).
   15. Switch to the final pixel resolution (512 x 512 or 1,024 x 1,024) depending on the speed of the moving subcellular structures or cells and select the scan speed (scan frequency) that fits best to the movements. Bidirectional scanning is recommended to fasten the acquisition of stacks.
       NOTE: Select the highest scan rate of scanning that gives sufficient image quality. Typical point scanners provide speeds between 400 Hz and 1.4 kHz. Resonant scanners provide an additional 8 kHz or 12 kHz. By reducing the number of lines in the y-direction, the scan rate can be further increased (typical values are 512 x 512, 512 x 256, or 512 x 200 pixel resolution). Depending on the signal-to-noise ratio, one can try to improve the image quality by adding line averaging between 2 and 4. Typically, a setting of 512 x 200 with no averaging results in an acquisition time/frame of 18 ms in the bidirectional mode with an 8 KHz resonant scanner; with 512 x 200 and 4x averaging, it slows down to 56 ms per frame.

Results

Intravital microscopy for the examination of tumor and collateral vessel growth triggered by monocytes can help reveal new aspects in the molecular mechanisms of tumor angiogenesis and arteriogenesis. Cells must be prepared and injected carefully using the steps of the protocol. Differences can lead to variations between single experiments. The monocytes must be injected into the venous system (Figure 1) to maintain systemic effects and avoid emboli, which ca...

Discussion

The method described here sheds light on the development of collateral arteries, the behavior of monocytes in these vessels, and the process of arteriogenesis. The steps for applying this protocol are easy to learn and can be used in other fields of science. Despite these advantages, there are some disadvantages. For instance, microscopic equipment is required to execute the described techniques. Obtaining equipment for one experiment is unsustainable, so it is important to collaborate with other institutions to share th...

Materials

Name	Company	Catalog Number	Comments
10% fetal calf serum (FCS)	Sigma Aldrich, Hamburg, Germany
1% penicillin/streptomycin	Sigma Aldrich, Hamburg, Germany
1mL Omnifix -F insuline syringe	B. Braun, Melsungen AG, Melsungen, Germany
50 ml syringe	Fresenius Kabi AG, Bad Homburg, Germany		Injectomat- syringe 50 ml with canule
6-well-ultra-low-attachement-plates	Corning Incorporated, NY, USA
8- 12 week old, male, C57BL/6, BalbC mice	Charles River, Sulzfeld, Germany
Adhesive tape	TESA SE, Hamburg, Germany
Acquisition Software	Leica, Wetzlar, Deutschland		Leica Application Suite Advanced Fluorescence (LAS AF); Version: 2.7.3.9723
Canules	B. Braun, Melsungen AG, Melsungen, Germany		29G, 30G
Cell culture dish	Greiner Bio-One GmbH, Frickenhausen, Germany
Cell culture medium	Manufactured by our group with single components		Medium199, 10% Fetal calf serum, 1% Antibiotic (penicillin/streptomycin)
Centrifuge	Beckman Coulter GmbH, Krefeld, Germany		Allegra X-15R centrifuge
Depilatory cream	Veet, Mannheim, Germany
DiO	Invitrogen Eugene, Oregon, USA
Disinfection agent	Schülke&Mayr GmbH, Norderstedt, Germany
Disposable scalpel No.10	Feather safety razor Co.Ltd, Osaka, Japan
EDTA	Sigma Aldrich, Hamburg, Germany
Erlenmeyer flask	GVB, Herzogenrath, Germany
Ethanol 70%	Otto Fischar GmbH und Co KG, Saarbrücken, Germany
Fetal Calf Serum	Sigma Aldrich, Hamburg, Germany
Fine Forceps	Rubis, Stabio, Switzerland
Flurophor/Rhodamindextran	Thermo Fischer Scientific, Waltham, MA USA	Katalognummer: D-1819
Gloves	Rösner-Matby Meditrade GmbH, Kiefersfelden, Germany
Heating pad	Labotect GmbH, Göttingen, Germany		Hot Plate 062
Human macrophage-colony stimulating factor	Sigma Aldrich, Hamburg, Germany	SRP3110
Humane leucocyte filters	Blood preservation
Incubator	Ewald Innovationstechnik GmbH, Bad Nenndorf, Germany
Isoflurane	Baxter Deutschland GmbH, Unterschleißheim, Germany
Ketamine (10%)	Ketavet, Pfizer Deutschland GmbH, Berlin , Germany
Leukocyte separation tubes (tubes with filter)	Bio one GmbH, Frickenhausen, Germany
Light microscope	Carl Zeiss SMT GmbH, Oberkochen, Germany		Axiovert 40 C
Lymphocyte separation medium LSM1077	GE Healthcare, Pasching, Austria
Matrigel	Becton, Dickinson and Company, Franklyn Lakes, New Jersey, USA
Medium M199	PAA Laboratories GmbH, Pasching, Austria
Microbiological work bench	Thermo Electron, LED GmbH, Langenselbold, Germany		Hera safe
Microscope slide	Carl Roth GmbH + Co. KG, Karlsruhe	Art. Nr. 1879
Microscope stand with incubator and heating unit	Leica DMI 6000, Pecon, Germany
Monocyte wash buffer	Manufactured by our group with single components		PBS, 0,5% BSA, 2mM EDTA
Mouse restrainer	Various
Multi-photon microscope	Leica, Wetzlar, Deutschland		Leica SP5 Confocal microscope, Cameleon, Coherent
NaCl (0,9%)	Berlin Chemie AG, Berlin, Germany
Neubauer counting chamber	Paul Marienfeld GmbH und Co.KG, Lauda-Königshofen, Germany
Objective	Leica, Wetzlar, Deutschland		Leica HC PL APO 10x/0.4 CS
PBS	Life technologies GmbH, Darmstadt, Germany		ph 7,4 sterile
Penicillin/Streptomycin	Sigma Aldrich, Hamburg, Germany
Percoll	Manufactured by our group with single components		90 % Percoll, 10% 1,5M NaCl, ρ= 1,064 g cm-3
Percoll solution	GE Healthcare, Bio-Science AB, Uppsala, Sweden
Pipettes	Eppendorf AG, Hamburg, Germany		10µL/100µL/200µL/1000µL
Pipettes serological	Greiner Bio-One GmbH, Frickenhausen, Germany		Cellstar2ml, 5ml, 10ml
Pipetting heads	Eppendorf AG, Hamburg, Germany
Pipetus	Eppendorf AG, Hamburg, Germany
Polystyrol tube	Cellstar, Greiner Bio-One GmbH, Frickenhausen, Germany
Scissor	Word Precision Instruments, Inc., Sarasota, USA
Scale	Mettler PM4800 Delta Range, Mettler-Toledo GmbH, Gießen, Germany
Suction unit	Integra bioscience, Fernwald, Germany		Vacusafe comfort
Surgical scissors	Word Precision Instruments, Inc., Sarasota, USA
Trypan blue solution 0,4 %	Sigma Aldrich, Hamburg, Germany
Tubes with cap	Greiner Bio-One GmbH, Frickenhausen, Germany		15ml, 50ml Cellstar
Xylazine (2 %)	Ceva Tiergesundheit GmbH, Düsseldorf, Germany